Citius Oncology Inc. Company Profile
NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.851+0.001 (+0.12%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Citius Oncology at a glance
Citius Oncology Inc. (NASDAQ: CTOR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cranford, NJ. The company's shares have traded publicly since 2022. At a market capitalization of $90.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001851484, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Citius Oncology Inc.
- Ticker
- NASDAQ: CTOR
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- 11 Commerce Drive, 1st Floor 07016, Cranford, NJ, United States
- Phone
- (908) 967-6677
- IPO year
- 2022
- Market cap
- $90.00M
- SEC CIK
- 0001851484
- Latest annual report
- 10-K · Dec 23, 2025
Companies similar to Citius Oncology
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RLYBRallybio Corporation | 16.93 | -0.88% | $89.94M | vs CTOR |
| EQEquillium Inc. | 1.39 | -2.11% | $88.14M | vs CTOR |
| MISTMilestone Pharmaceuticals Inc. | 0.7572 | -0.92% | $94.27M | vs CTOR |
| OKUROnKure Therapeutics Inc. Class A | 2.35 | -4.47% | $95.17M | vs CTOR |
| BMEABiomea Fusion Inc. | 1.32 | +5.60% | $95.44M | vs CTOR |
| TELOTelomir Pharmaceuticals Inc. | 1.12 | -6.67% | $82.45M | vs CTOR |
| PMNProMIS Neurosciences Inc. | 9.12 | -0.98% | $81.79M | vs CTOR |
| ACRVAcrivon Therapeutics Inc. | 1.88 | +1.08% | $80.56M | vs CTOR |